Replication rates in biomedical AI are reportedly below 50%. Yet performance claims keep multiplying. Without shared benchmarking standards, how does drug discovery separate real progress from noise? https://t.co/vGuts4pNHe #AIDrugDiscovery#Benchmarking#DrugDiscovery
Strong values don't protect against burnout. For many healthcare professionals, they fuel it.
Registered psychologist Amberley Meredith examines the psychological drivers behind overextension. https://t.co/aoQX35ABKB #Burnout#Healthcare#Wellbeing
One infusion of VERVE-102 cut LDL by up to 62% with no serious adverse events. So where does base editing now sit vs CRISPR? We break it down. https://t.co/12CFSiGQdP #BaseEditing#CRISPR#Biotech
The wellness tourism market is on track to hit $1.35 trillion by 2028. Health tech is a key driver, connecting patients with longevity and regenerative therapies across borders.
New on @LifeScienceDN https://t.co/m93b5MAlhi #HealthTech#GlobalHealthcare#LifeSciences
Most disease begins long before diagnosis. So why does prevention still start so late?
Dr Jasmin Tzortzakakis Malik examines the physiology that medicine often misses. Read here: https://t.co/3lwMsikdAa
#PreventiveHealth#Primarycare#PublicHealth
AI won't solve healthcare inequality. But could it lower the barriers limiting who participates in clinical research? Amanda McLean shares a practitioner's perspective.
https://t.co/46WyL0OAXe
#ClinicalTrials#HealthEquity#AIinHealthcare
Stanford's CRISPR-GPT lets novice researchers achieve up to 90% gene editing efficiency on their first attempt.
Developed with Princeton, UC Berkeley & Google DeepMind. Published in Nature Biomedical Engineering. https://t.co/5SMvaOJQhp #CRISPR#GeneEditing#Biotech
65% of mothers surveyed across Tamil Nadu showed depressive symptoms. 8% had any mental health support. Climate stress is entering households long before it enters clinics. https://t.co/CNvPENmAYV #MaternalHealth#ClimateAndHealth#GlobalHealth
Good science alone doesn't get therapies to patients.
Leen Kawas on why execution is biotech's real missing ingredient and what the post-2021 market reset changed for investors.
https://t.co/dt7h2lSDwP https://t.co/ZRQJ6cmMYM #Biotech#Biopharma
67% of biopharma leaders drop AI projects due to poor data quality. New article explores why a harmonised data foundation is the fix. https://t.co/IIGcwICarY #Biopharma#DataQuality#AI
New Post: Burnout in life sciences isn't a resilience failure. It's what happens when systems demand more than they allow people to recover from. https://t.co/7jpppoXxpo #LifeSciences#Burnout#Healthcare
New Post: Lilly's retatrutide hits 28% weight loss in Phase 3. First HDV therapy approved. First-line TNBC approval for Datroway. This week's life science roundup covers six major clinical and regulatory milestones. https://t.co/aFqqUTMMhN #LifeSciences#Pharma#FDA